Andreessen Horowitz funds report 6.1% Omada Health (OMDA) ownership stake

Rhea-AI Filing Summary

Omada Health, Inc. and Andreessen Horowitz-affiliated funds report their ownership positions in Omada’s common stock as of December 31, 2025. Andreessen Horowitz Fund IV, L.P. holds 3,157,951 shares, representing 5.5% of the company’s common stock, while AH Parallel Fund IV, L.P. holds 302,978 shares, or 0.5%.

Marc L. Andreessen reports beneficial ownership of 3,540,847 shares, and Benjamin A. Horowitz reports 3,538,143 shares, each representing 6.1% of the outstanding common stock. These percentages are based on 57,908,047 shares outstanding as of November 5, 2025, and reflect voting and dispositive powers held through various Andreessen Horowitz entities and family trusts.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Omada Health, Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

68170A108

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Andreessen Horowitz Fund IV, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,157,951.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,157,951.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,157,951.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

AH Equity Partners IV, L.L.C.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,157,951.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,157,951.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,157,951.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

AH Parallel Fund IV, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 302,978.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 302,978.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

302,978.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.5 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

AH Equity Partners IV (Parallel), L.L.C.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 302,978.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 302,978.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

302,978.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.5 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Marc L. Andreessen

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,540,847.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,540,847.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,540,847.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.1 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Benjamin A. Horowitz

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,538,143.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,538,143.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,538,143.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.1 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Omada Health, Inc.
(b)	Address of issuer's principal executive offices: 611 Gateway Blvd, Suite 120, South San Francisco, CA, 94080.
Item 2.
(a)	Name of person filing: The names of the persons filing this report (collectively, the "Reporting Persons") are: Andreessen Horowitz Fund IV, L.P. ("AH IV") AH Equity Partners IV, L.L.C. ("AH Equity IV") AH Parallel Fund IV, L.P. ("AH Parallel IV") AH Equity Partners IV (Parallel), L.L.C. ("AH Equity Parallel IV") Marc L. Andreessen ("Andreessen") Benjamin A. Horowitz ("Horowitz") The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G.
(b)	Address or principal business office or, if none, residence: The address for each of the Reporting Persons is: Andreessen Horowitz 2865 Sand Hill Road, Suite 101 Menlo Park, CA 94025
(c)	Citizenship: AH IV Delaware AH Equity IV Delaware AH Parallel IV Delaware AH Equity Parallel IV Delaware Andreessen United States Horowitz United States
(d)	Title of class of securities: Common Stock, $0.001 par value
(e)	CUSIP No.: 68170A108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of shares of common stock of the Issuer beneficially owned by such Reporting Person as of December 31, 2025 and is incorporated by reference. The Reporting Persons' ownership of the Issuer's securities includes (i) 3,157,951 shares of common stock directly held by AH IV for itself and as nominee of Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P. and Andreessen Horowitz Fund IV-Q, L.P.; (ii) 302,978 shares of common stock directly held by AH Parallel IV for itself and as nominee of AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B, L.P., and AH Parallel Fund IV-Q, L.P; (iii) 79,918 shares of common stock directly held by the LAMA Community Trust; and (iv) 77,214 shares of common stock directly held by the 1997 Horowitz Family Trust. AH Equity IV is the general partner of AH IV and may be deemed to have sole power to vote and sole power to dispose of the shares of the Issuer held of record by AH IV for itself and as nominee of Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P. and Andreessen Horowitz Fund IV-Q, L.P. Andreessen and Horowitz are managing members of AH Equity IV and may be deemed to have shared voting and shared dispositive power over the shares held of record by AH IV for itself and as nominee. AH Equity Parallel IV is the general partner of AH Parallel IV and may be deemed to have sole power to vote and sole power to dispose of shares of the Issuer held of record by AH Parallel IV for itself and as nominee of AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B, L.P., and AH Parallel Fund IV-Q, L.P. Andreessen and Horowitz are managing members of AH Equity Parallel IV and may be deemed to have shared voting and shared dispositive power over the shares held of record by AH Parallel IV for itself and as nominee. Andreessen is a trustee of the LAMA Community Trust and may be deemed to have shared voting and shared dispositive power over the shares held of record by the LAMA Community Trust. Horowitz is a trustee of the 1997 Horowitz Family Trust and may be deemed to have shared voting and shared dispositive power over the shares held of record by the 1997 Horowitz Family Trust.
(b)	Percent of class: Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the shares of common stock of the Issuer beneficially owned by such Reporting Person as of December 31, 2025 and is incorporated by reference. The percentage set forth in each row 11 is based upon 57,908,047 shares of common stock outstanding as of November 5, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on November 7, 2025.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of December 31, 2025 and is incorporated by reference.
	(ii) Shared power to vote or to direct the vote: Row 6 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of December 31, 2025 and is incorporated by reference.
	(iii) Sole power to dispose or to direct the disposition of: Row 7 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of December 31, 2025 and is incorporated by reference.
	(iv) Shared power to dispose or to direct the disposition of: Row 8 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of December 31, 2025 and is incorporated by reference.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Under certain circumstances set forth in the limited partnership agreements of each of AH IV and AH Parallel IV and the limited liability company agreements of AH Equity IV and AH Equity Parallel IV, the general partner and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the Issuer owned by each such entity of which they are a partner or a member, as the case may be.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Andreessen Horowitz Fund IV, L.P.

Signature:	/s/ Phil Hathaway
Name/Title:	By AH Equity Partners IV, L.L.C., Its General Partner, By Phil Hathaway, Chief Operating Officer (See Note 1)
Date:	02/17/2026

AH Equity Partners IV, L.L.C.

Signature:	/s/ Phil Hathaway
Name/Title:	By Phil Hathaway, Chief Operating Officer
Date:	02/17/2026

AH Parallel Fund IV, L.P.

Signature:	/s/ Phil Hathaway
Name/Title:	By AH Equity Partners IV (Parallel), L.L.C., Its General Partner, By Phil Hathaway, Chief Operating Officer (See Note 2)
Date:	02/17/2026

AH Equity Partners IV (Parallel), L.L.C.

Signature:	/s/ Phil Hathaway
Name/Title:	By Phil Hathaway, Chief Operating Officer
Date:	02/17/2026

Marc L. Andreessen

Signature:	/s/ Phil Hathaway
Name/Title:	By Phil Hathaway, Attorney-in-Fact
Date:	02/17/2026

Benjamin A. Horowitz

Signature:	/s/ Phil Hathaway
Name/Title:	By Phil Hathaway, Attorney-in-Fact
Date:	02/17/2026

Comments accompanying signature: Note 1: Andreessen Horowitz Fund IV, L.P. for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P. and Andreessen Horowitz Fund IV-Q, L.P. Note 2: AH Parallel Fund IV, L.P. for itself and as nominee for AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B L.P. and AH Parallel Fund IV-Q, L.P.

Exhibit Information

Exhibit 24.1 Power of Attorney for Marc L. Andreessen, dated June 23, 2023 (incorporated by reference to Exhibit 24.1 to the Reporting Persons' Schedule 13G filed with the SEC on August 14, 2025). Exhibit 24.2 Power of Attorney for Benjamin A. Horowitz, dated June 22, 2023 (incorporated by reference to Exhibit 24.2 to the Reporting Persons' Schedule 13G filed with the SEC on August 14, 2025). Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on August 14, 2025).

FAQ

What ownership stake in Omada Health, Inc. (OMDA) does Andreessen Horowitz Fund IV report?

Andreessen Horowitz Fund IV, L.P. reports beneficial ownership of 3,157,951 shares of Omada Health common stock. This position represents 5.5% of Omada’s outstanding common shares, based on 57,908,047 shares outstanding as of November 5, 2025, disclosed in Omada’s Form 10-Q.

How much of Omada Health, Inc. (OMDA) does AH Parallel Fund IV own?

AH Parallel Fund IV, L.P. reports beneficial ownership of 302,978 shares of Omada Health common stock. This equates to 0.5% of the company’s outstanding common shares, using the 57,908,047 shares outstanding figure from Omada’s November 5, 2025 share count in its Form 10-Q.

What percentage of Omada Health, Inc. (OMDA) is beneficially owned by Marc L. Andreessen?

Marc L. Andreessen reports beneficial ownership of 3,540,847 shares of Omada Health, representing 6.1% of the outstanding common stock. His interest is held through Andreessen Horowitz funds and the LAMA Community Trust, reflecting shared voting and dispositive power over those securities.

What is Benjamin A. Horowitz’s reported stake in Omada Health, Inc. (OMDA)?

Benjamin A. Horowitz reports beneficial ownership of 3,538,143 shares of Omada Health common stock. This equals 6.1% of the company’s outstanding shares, including interests held through Andreessen Horowitz entities and the 1997 Horowitz Family Trust, with shared voting and dispositive authority.

On what share count are the Omada Health, Inc. (OMDA) ownership percentages based?

All reported ownership percentages use 57,908,047 shares of Omada Health common stock outstanding as the baseline. This figure comes from Omada’s Form 10-Q, which stated that 57,908,047 common shares were outstanding as of November 5, 2025.

Do the Andreessen Horowitz reporting persons file as a group for Omada Health, Inc. (OMDA)?

The filing states that the Andreessen Horowitz-affiliated reporting persons expressly disclaim status as a “group” for beneficial ownership purposes. Each entity and individual reports their holdings separately, even though certain voting and dispositive powers are shared through fund and trust structures.